AUS
NZ
UK
CA
USA
IND
Highlights
- The FTSE 100 has stood firm amid a global volatile market, falling by just 2%.
- S&P 500 and Nasdaq dipped by 19% and 31%, respectively.
- Even though FTSE's exposure in tech stocks, healthcare consumer staples etc., did manage to dodge some of the market pains.
For many investors, the year 2022 has been a rather forgettable one. In fact, popular stocks plummeted amid increasing inflationary pressures and a rising cost-of-living crisis. Some of the things that plagued the market this year were rising interest rates, high energy prices owing to Russia Ukraine war, disastrous mini-budget, and strikes which dented the movements of the general population, etc.
But despite all this, the FTSE 100 has stood firm amid a global volatile market, falling by just 2%, while the likes of the S&P 500 and Nasdaq dipped by 19% and 31%, respectively.
Even though FTSE's exposure in tech stocks, healthcare consumer staples etc., did manage to dodge some of the market pains, the hospitality stocks bore the brunt of the market pressures, with several retail joints shutting shop owing to rising energy prices. In fact, it would be safe to say that it has been an eventful year since the global financial crisis.
Amid all this, Kalkine Media® explores 10 stocks which have topped the charts in the volatile 2022.
BAE Systems Plc (LON: BA.)
The UK-based BAE Systems Plc is one of the most advanced technology-led aerospace, defence and security solutions providers offering varied services across 40 countries, including the UK, Saudi Arabia, the US etc. BA. has topped the charts giving returns of 61.89% over the past 12 months. Boasting a market cap of £26,219.42 million, BA. registered YTD gains of 54.02% with an EPS of 0.55. BAE Systems, as on 21 December, was down by -4.40 and was trading at GBX 846.80.
Glencore PLC (LON:GLEN)
The Anglo-Swiss multinational commodity trading and mining firm is spread across 35 countries. The Deutsche Bank had voted Glencore one of the best mining companies of the year. Over the past year, the FTSE 100 Index constituent has registered gains of 52.99% as of 21 December. GLEN stock on Wednesday was trading at GBX 550.10, up by 0.38%. With a market cap of £70,362.34 million, GLEN stock has registered YTD gains of 46.71%. Glencore Plc stock had an EPS (earnings per share) of 0.38.
BP Plc (LON: BP)
UK-based global oil and gas company BP plc operates across Europe, the Americas, Australia, Asia and Africa. The FTSE 100 Index constituent, in the past 12 months, has been one of the top gainers on the exchange, registering gains of 45.35% and 37.37% on a YTD basis as on 21 December. BP stock on Wednesday was trading at GBX 477.70, up by 2.19%. With a market cap of £84,335.33 million, BP stock had an EPS (earnings per share) of 0.38 at the time of writing.
Centrica Plc (LON:CNA)
An international energy services and solutions company, Centrica Plc caters to over 12 million customers. Earlier this month, CNA announced that it would help customers save power. For this, Centrica's British Gas is set to target over 100,000 smart-meter households to urge them to reduce their electricity consumption by 30% during peak hours. CNA, over the past one year, has managed a healthy gain on both a yearly and YTD basis. Centrica Plc has given its investors gains of over 44.05% and 30.22%, respectively. With a market cap of £5,539.68 million, Centrica shares were trading at GBX 95.54, up by 1.23%.
Imperial Brands PLC (LON: IMB)
Imperial Brands Plc has topped several other big names within the FTSE 100, registering massive gains of 30.85% and 27.87% on a yearly and YTD basis. With a market cap of £ 19,393.01 million, IMB shares were up by 0.24% and were trading at GBX 2,071.00. The company manufactures and sells different types of cigarettes and tobacco products had an EPS of 3.0.
Note: The above content constitutes a very preliminary observation or view based on industry trends and is of limited scope without any in-depth fundamental valuation or technical analysis. Any interest in stocks or sectors should be thoroughly evaluated taking into consideration the associated risks.
